Preanalytical factors of importance for measurement of Chromogranin A

Clinica Chimica Acta

Volumn 436, Issue , 2014, Pages 41-44

  Pedersen, Lise ^a   Nybo, Mads ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Biological variation; Chromogranin A; Neuroendocrine tumor; Pre analytical phase; Quality requirements; Reference range

Indexed keywords

CHROMOGRANIN A; EPITOPE;

ACCURACY; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BLOOD STORAGE; CIRCADIAN RHYTHM; DIET RESTRICTION; FEMALE; HUMAN; IMMUNOASSAY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN STABILITY; REFERENCE VALUE; REPEAT PROCEDURE; SEX DIFFERENCE; ARTIFACTS; BLOOD; BLOOD CHEMICAL ANALYSIS; FASTING; HUMANS; METHODS; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; ARTIFACTS; BLOOD CHEMICAL ANALYSIS; CHROMOGRANIN A; FASTING; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84901362857     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.04.026     Document Type: Article

References (12)

1. Lynggaard L.A., Nielsen E.H., Laurberg P. Carcinoid syndrome caused by a serotonin secreting pituitary tumor. Eur J Endocrinol February 1, 2014, K5-K9.
2. Rao F., Keiser H.R., O'Connor D.T. Malignant and benign pheochromocytoma: chromaffin granule transmitters and the response to medical and surgical treatment. Ann N Y Acad Sci 2002, 971:530-532.
3. Sondenaa K., Sen J., Heinle F., Fjetland L., Gudlaugsson E., Syversen U. Chromogranin A, a marker of the therapeutic success of resection of neuroendocrine liver metastases: preliminary report. World J Surg 2004, 28:890-895.
4. Taupenot L., Harper K.L., O'Connor D.T. The chromogranin-secretogranin family. N Engl J Med 2003, 348:1134-1149.
5. Borch K., Stridsberg M., Burman P., Rehfeld J.F. Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis. Scand J Gastroenterol 1997, 32:198-202.
6. Canale M.P., Bravo E.L. Diagnostic specificity of serum chromogranin-A for pheochromocytoma in patients with renal dysfunction. J Clin Endocrinol Metab 1994, 78:1139-1144.
7. Ceconi C., Ferrari R., Bachetti T., et al. Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality. Eur Heart J 2002, 23:967-974.
8. O'Connor D.T., Pandlan M.R., Carlton E., Cervenka J.H., Hslao R.J. Rapid radioimmunoassay of circulating chromogranin A: in vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure. Clin Chem 1989, 35:1631-1637.
9. Takiyyuddin M.A., Parmer R.J., Kailasam M.T., et al. Chromogranin A in human hypertension. Influence of heredity. Hypertension 1995, 26:213-220.
10. Stridsberg M., Eriksson B., Oberg K., Janson E.T. A comparison between three commercial kits for chromogranin A measurements. J Endocrinol 2003, 177:337-341.
11. Fossmark R., Jianu C.S., Martinsen T.C., Qvigstad G., Syversen U., Waldum H.L. Serum gastrin and chromogranin A levels in patients with fundic gland polyps caused by long-term proton-pump inhibition. Scand J Gastroenterol 2008, 43:20-24.
12. Korse C.M., Baan A., Tesselaar M.E. Comparison of the automated chromogranin A assay using Kryptor instrumentation with the Manual IRMA Assay of CisBio. Poster from 9th Annual ENETS Conference Copenhagen March 7-9 2012.